MGMT methylation status may predict survival in elderly patients with newly diagnosed glioblastoma (GBM)

被引：0
|
作者：
Gerstner, E. R. [1 ]
Yip, S. [1 ]
Wang, D. L. [1 ]
Louis, D. N. [1 ]
Iafrate, A. J. [1 ]
Batchelor, T. T. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13023
引用
收藏
页数：1
相关论文
共 50 条
  • [1] MGMT METHYLATION IS A PROGNOSTIC BIOMARKER IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Gerstner, E. R.
    Yip, S.
    Wang, D. L.
    Louis, D. N.
    Iafrate, A. J.
    Batchelor, T. T.
    [J]. NEUROLOGY, 2009, 73 (18) : 1509 - 1510
  • [2] Institutional Validation Study Inferring 2% MGMT Methylation Positive Impact on Survival in Newly Diagnosed Glioblastoma (GBM) Patients
    Cappelli, L.
    Poiset, S. J.
    Khan, M.
    Kayne, A.
    Nelson, N. G.
    Gardner, C.
    Uppendahl, A.
    Zhan, T.
    Wang, Z. X.
    Judy, K.
    Andrews, D. W.
    Alnahhas, I.
    Shi, W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E92 - E93
  • [3] A score to predict survival of elderly patients newly diagnosed for Glioblastoma
    Straube, C.
    Kessel, K. A.
    Antoni, S.
    Gempt, J.
    Meyer, B.
    Schlegel, J.
    Schmidt-Graf, F.
    Combs, S. E.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S191 - S192
  • [4] A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma
    Christoph Straube
    Kerstin A. Kessel
    Stefanie Antoni
    Jens Gempt
    Bernhard Meyer
    Juergen Schlegel
    Friederike Schmidt-Graf
    Stephanie E. Combs
    [J]. Radiation Oncology, 15
  • [5] A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma
    Straube, Christoph
    Kessel, Kerstin A.
    Antoni, Stefanie
    Gempt, Jens
    Meyer, Bernhard
    Schlegel, Juergen
    Schmidt-Graf, Friederike
    Combs, Stephanie E.
    [J]. RADIATION ONCOLOGY, 2020, 15 (01)
  • [6] MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients
    Brandes, Alba A.
    Franceschi, Enrico
    Tosoni, Alicia
    Blatt, Valeria
    Pession, Annalisa
    Tallini, Giovanni
    Bertorelle, Roberta
    Bartolini, Stefania
    Calbucci, Fabio
    Andreoli, Alvaro
    Frezza, Giampiero
    Leonardi, Marco
    Spagnolli, Federica
    Ermani, Mario
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (13) : 2192 - 2197
  • [7] MGMT PROMOTER METHYLATION STATUS IN NEWLY DIAGNOSED GLIOBLASTOMAS (GBM): RETROSPECTIVE ANALYSIS FROM A CLINICAL SERIES OF PATIENTS
    Garcia, M. Martinez
    Tortosa, A.
    Maldonado, X.
    Gonzalez, S.
    Balana, C.
    Gallego, O.
    Verger, E.
    Fuentes, R.
    Navarro, V.
    Gil, M. Gil
    [J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1126 - 1126
  • [8] MGMT Promoter Methylation Status and Overall Survival in Glioblastoma Patients
    Xia, Daniel
    Lindeman, Neal
    [J]. MODERN PATHOLOGY, 2016, 29 : 437A - 437A
  • [9] MGMT Promoter Methylation Status and Overall Survival in Glioblastoma Patients
    Xia, Daniel
    Lindeman, Neal
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 437A - 437A
  • [10] Novel RPA classification combining MGMT promoter methylation status in newly diagnosed glioblastoma
    Wee, C. W.
    Kim, E.
    Kim, I. A.
    Kim, T. M.
    Kim, Y. J.
    Park, C. K.
    Kim, J. W.
    Kim, C. Y.
    Choi, S. H.
    Kim, J. H.
    Park, S. H.
    Choe, G.
    Lee, S. T.
    Kim, I. H.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S265 - S265
12345